文献速递造血干细胞移植与细胞治疗

供者T细胞Stat3基因敲除对小鼠急性肠道移植物抗宿主病的影响

[Effects of donor T cell stat3 deficiency on acute intestinal graft-versus-host disease in mice].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2025-01-01

该研究通过清髓辐照后输注供者骨髓和脾脏细胞构建小鼠aGVHD模型,比较野生型与Stat3敲除T细胞对急性肠道GVHD的影响。结果显示Stat3-KO组生存率更高、体重下降及肠道炎症较轻、肠黏膜屏障与干细胞相关指标改善,且GVL效应保留,80%小鼠无肿瘤存活超过100天(P<0.05)。

要点

  • Stat3-KO组较WT组生存率更高、体重下降及弓背腹泻等症状更轻(P<0.05)。
  • Stat3-KO组血清IL-2、IL-6、IFN-γ、TNF-α、IL-17A、IL-10浓度及肠道炎症细胞浸润均低于WT组(均P<0.05)。
  • GVL模型中Stat3-KO组80%小鼠无肿瘤存活超过100天(P<0.05)。

核心结论

  • 敲除供者T细胞Stat3基因可减轻T细胞对肠道干细胞的损伤,从而缓解GI-aGVHD,同时保留稳定的GVL效应。

研究设计与样本

  • 对BALB/c小鼠清髓剂量辐照后经尾静脉输注同基因对照、C57BL/6野生型T细胞或C57BL/6J-Stat3(em1cyagen)敲除T细胞的骨髓和脾脏细胞构建aGVHD模型。
  • 监测生存率、体重及临床评分,检测血清细胞因子、组织淋巴细胞流式、肠道病理、肠道通透性、Ki67与Muc2免疫组化及小肠Olfm4、Lysozyme、Muc2基因表达。
  • 进行血清和肠道代谢组学检测,并构建小肠类器官与T细胞共培养体外GI-aGVHD模型观察类器官数量与面积。
  • 通过接种荧光素酶转染的ALL/Luc细胞和生物发光成像评估GVL效应。

主要发现

  • 与WT组相比,Stat3-KO组小鼠体重下降、弓背、腹泻等症状较轻,生存率较高(P<0.05)。
  • 与WT组相比,Stat3-KO组血清IL-2、IL-6、IFN-γ、TNF-α、IL-17A及IL-10浓度较低(均P<0.05),肠道炎症细胞浸润及肠黏膜通透性减弱(均P<0.05)。
  • Stat3-KO组小肠Muc2和Ki67表达显著上调(均P<0.05),Olfm4、Lysozyme和Muc2基因表达水平亦明显上调(均P<0.05)。
  • 体外实验显示Stat3-KO组类器官发育优于WT组;代谢组学分析提示敲除供者T细胞Stat3基因可能与调节胆汁酸及不饱和脂肪酸代谢相关。
  • GVL小鼠模型中TCD-BM组ALL/Luc细胞迅速生长,而Stat3-KO组未观察到肿瘤生长,80%小鼠无肿瘤存活期超过100天(P<0.05)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effects and underlying mechanisms of Stat3 knockout in donor T cells on acute gastrointestinal graft-versus-host disease (GI-aGVHD) . Methods: BALB/c mice were exposed to lethal irradiation and transplanted with bone marrow and spleen cells from BALB/c mice (syngeneic control group), C57BL/6 mice (wild-type T cell group, WT group), or C57BL/6J-Stat3(em1cyagen) mice (Stat3 gene knockout T cell group, Stat3-KO group) via tail vein injection to establish the aGVHD model. The survival rate, body weight changes, and clinical scores of mice were monitored. Cytometric bead array (CBA) was used to detect the concentrations of serum cytokines. Lymphocytes were isolated from tissues for flow cytometric analysis. H&E staining was performed to observe intestinal pathological changes. FITC-dextran assay was conducted to assess intestinal permeability. Immunohistochemistry was used to evaluate the expression of Ki67 and Muc2. Real-Time Quantitative Reverse Transcription PCR (qRT-PCR) was employed to analyze the gene expression levels of Olfm4, Lysozyme, and Muc2 in the small intestine. Metabolomics was conducted to detect metabolites in serum and intestinal tissues. An in vitro GI-aGVHD organoid model was established by coculturing intestinal organoids with allogeneic T cells, where the number and area of small intestinal organoids were recorded. The GVL effect was assessed using luciferase-transfected ALL cells (ALL/Luc) and bioluminescent imaging. Results: Compared with the WT group, Stat3 knockout T cells alleviated body weight loss, reduced symptoms-such as hunchback and diarrhea-in mice, improved survival rate (P<0.05), and reduced serum interleukin (IL) -2, IL-6, interferon-γ, tumor necrosis factor-α, IL-17A, and IL-10 levels (all P<0.05), intestinal inflammatory cell infiltration (P<0.05), and intestinal mucosal permeability. Further, Muc2 and Ki67 expression levels in the small intestine of the Stat3 knockout group were markedly increased, and Olfm4, Lysozyme, and Muc2 gene expression levels were significantly increased (all P<0.05). In vitro, the Stat3 knockout group demonstrated better organoid development than the WT group. Metabolomic analyses indicated that Stat3 knockout in T cells may affect the pathways associated with bile acid secretion and unsaturated fatty acids. ALL/Luc cells in the GVL mouse model proliferated rapidly in the TCD-BM group; however, 80% of the mice in the Stat3-KO group survived tumor-free for >100 days (P<0.05) . Conclusion: Knocking out Stat3 in graft T cells reduces T cell damage to intestinal stem cells, thereby ultimately alleviating GI-aGVHD while maintaining a stable GVL effect. 目的: 探讨供者T细胞Stat3基因敲除对急性肠道移植物抗宿主病(GI-aGVHD)的影响及其机制。 方法: 对BALB/c小鼠进行清髓剂量辐照,经尾静脉输注BALB/c小鼠(同基因对照组)、C57BL/6小鼠(野生型T细胞组,WT组)及C57BL/6J-Stat3(em1cyagen)小鼠(Stat3基因敲除T细胞组,Stat3-KO组)的骨髓和脾脏细胞构建aGVHD模型。监测小鼠生存率、体重变化及临床评分,流式微球阵列术检测血清细胞因子浓度,分离组织中的淋巴细胞进行流式细胞术分析,HE染色后观察肠道病理学变化,FITC-葡聚糖检测肠道通透性,免疫组化评估Ki67和Muc2的表达,实时荧光定量逆转录PCR(qRT-PCR)分析小肠Olfm4、Lysozyme和Muc2的基因表达水平,代谢组学检测血清和肠道代谢物。同时,构建小肠类器官与T细胞的共培养体系,体外模拟GI-aGVHD模型,观察类器官数量与面积变化。此外,通过接种荧光素酶转染的急性淋巴细胞白血病(ALL/Luc)细胞和生物发光成像来评估移植物抗白血病(GVL)效应。 结果: 与WT组相比,Stat3-KO组小鼠临床症状(体重下降、弓背、腹泻)较轻,生存率较高(P<0.05),IL-2、IL-6、IFN-γ、TNF-α、IL-17A以及IL-10血清浓度较低(均P<0.05),肠道炎症细胞浸润及肠黏膜通透性减弱(均P<0.05)。此外,Stat3-KO组小肠Muc2和Ki67表达显著上调(均P<0.05),Olfm4、Lysozyme和Muc2基因的表达水平亦明显上调(均P<0.05)。体外实验显示,Stat3-KO组的类器官发育优于WT组。代谢组学分析提示,敲除供者T细胞Stat3基因减轻GI-aGVHD可能与调节胆汁酸及不饱和脂肪酸代谢相关。在GVL小鼠模型中,回输去除T细胞的骨髓细胞(TCD-BM组)的ALL/Luc细胞迅速生长,而Stat3-KO组未观察到肿瘤生长,80%小鼠的无肿瘤存活期超过100 d (P<0.05)。 结论: 敲除供者T细胞Stat3基因可减轻T细胞对肠道干细胞的损伤,从而缓解GI-aGVHD的肠道损伤,同时保留稳定的GVL效应。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Xu YX, Wang XQ, Yang SJ, et al. [Effects of donor T cell stat3 deficiency on acute intestinal graft-versus-host disease in mice]. Zhonghua Xue Ye Xue Za Zhi. 2025. PMID: 40425451. doi:10.3760/cma.j.cn121090-20250107-00011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。